Drugs / RO7663498
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07588100 | Jun 2026 → Dec 2027 expected | diabetic retinopathy | Hoffmann-La Roche | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7663498 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07588100 ↗ |
| Route | Intravitreal | “intravitreal (IVT) injections” NCT07588100 ↗ |